Content for healthcare professionals only

View all Platforms Cardiology

Topics Content Type Videos Articles Journals Broadcasts Education Podcasts News Journals AER CFR ECR ICR3 JAPSC USC Faculty Events Upcoming Events Radcliffe Events All Events Resource Hubs Deep Vein Thrombosis Empagliflozin in the Treatment of Chronic Heart Failure Pulmonary Embolism Pulsed Field Ablation

Radcliffe Platforms

Radcliffe Group Cardiology Vascular CVRM Medical Education

Content for healthcare professionals only

Content Type

Events

Resource Hubs

Dirk Sibbing

Dirk Sibbing

Ludwig-Maximilians-University, Munich, Germany

Expertise

Anticoagulation Prevention & Chronic Conditions Coronary Artery Disease and Myocardial Infarction Antiplatelet Unstable Angina & NSTEMI MI/ACS STEMI

Media

De-Escalation Of Antiplatelet Treatment In ACS Patients Undergoing PCI At ESC 2017

Video

Anticoagulation

ESC 2017: TROPICAL-ACS - De-Escalation of Antiplatelet Treatment in ACS…

Watch time: 5m 16s

Articles by Dirk Sibbing

Dual-pathway Inhibition with Low-dose Aspirin and Rivaroxaban versus Aspirin Monotherapy in Patients with Coronary Artery Disease and Peripheral Artery Disease: Systematic Literature Review and Meta-analysis

Dirk Sibbing, Michael J Blaha, Rajinder Chawla, et al

Published: 05 April 2024

Citation: European Cardiology Review 2024;19:e01.

DOI:

https://doi.org/10.15420/ecr.2023.40